SYRS Stock Summary and Trading Ideas (Syros Pharmaceuticals | NASDAQ:SYRS)

Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.

Syros Pharmaceuticals trades on the NASDAQ stock market under the symbol SYRS.

As of May 10, 2024, SYRS stock price declined to $4.97 with 137,174 million shares trading.

SYRS has a beta of 1.34, meaning it tends to be more sensitive to market movements. SYRS has a correlation of 0.03 to the broad based SPY ETF.

SYRS has a market cap of $132.84 million. This is considered a Micro Cap stock.

Last quarter Syros Pharmaceuticals reported $387,000 in Revenue and -$2.18 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$1.04.

In the last 3 years, SYRS stock traded as high as $70.30 and as low as $2.09.

The top ETF exchange traded funds that SYRS belongs to (by Net Assets): VTI, VXF, IWC, AVSC.

SYRS has outperformed the market in the last year with a return of +44.9%, while the SPY ETF gained +27.8%. However, in the most recent history, SYRS shares have underperformed the stock market with its stock returning -29.7% in the last 3 month period and -1.4% for the last 2 week period, while SPY has returned +4.2% and +2.5%, respectively.

SYRS support price is $4.76 and resistance is $5.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SYRS stock will trade within this expected range on the day.